1. Short title; table of contents (a) Short title This Act may be cited as the Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act or the SCREEN Act . (b) Table of contents The table of contents of this Act is as follows: Sec. 1. Short title; table of contents. Sec. 2. Detention, refusal, and destruction of drugs offered for importation. Sec. 3. Notification, nondistribution, and recall of adulterated or misbranded drug products. Sec. 4. Seizure. Sec. 5. Single source pattern of shipments of adulterated or misbranded drugs. Sec. 6. Debarring violative individuals or companies. Sec. 7. Account to strengthen efforts of FDA to combat the opioid and substance use epidemic. 2. Detention, refusal, and destruction of drugs offered for importation (a) Certain imported products deemed To be drugs Section 201(g) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(g) ) is amended by adding at the end the following: (3) An article being imported or offered for import is deemed to be a drug if it— (A) is or contains an active ingredient that is contained within— (i) a drug for which an approval is in effect under section 505 of this Act; or (ii) biological product for which a license is in effect under section 351 of the Public Health Service Act; (B) is or contains an active ingredient that is contained within a drug or biological product for which an investigational use exemption is in effect under section 505(i) of this Act or section 351(a) of the Public Health Service Act, for which substantial clinical investigations have been instituted, and for which the existence of such investigations has been made public